Medicare Part D 2017 Formulary Changes OC Preferred
|
|
|
- Simon Snow
- 5 years ago
- Views:
Transcription
1 Medicare Part D 2017 Formulary Changes OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization, quantity limits and/or step therapy restrictions or move a drug to a higher cost-sharing tier, we will notify you of the change at least 60 days before the date that the change becomes effective. However, if the U.S. Food and Drug Administration (FDA) determines a drug on our formulary to be unsafe or the drug s manufacturer removes the drug from the market, we will immediately remove the drug from our formulary. The table below outlines changes made to our formulary throughout VERSION: FORMULARY ADDITIONS UPDATE AS OF OCTOBER 1, 2017: FORMULARY ID: Formulary additions, reductions in preferred or tiered cost-sharing status, or removal of Utilization Management to an existing formulary drug Covered Drug Name Alternate Drug Name Description of Change Effective Date of Change Tier Utilization Management Notes ATOMOXETINE CAP 10MG STRATTERA ADDITION 10/1/ QL (60 PER 30 DAYS) ATOMOXETINE CAP 18MG STRATTERA ADDITION 10/1/ QL (60 PER 30 DAYS) ATOMOXETINE CAP 25MG STRATTERA ADDITION 10/1/ QL (60 PER 30 DAYS) ATOMOXETINE CAP 40MG STRATTERA ADDITION 10/1/ QL (60 PER 30 DAYS) ATOMOXETINE CAP 60MG STRATTERA ADDITION 10/1/ QL (60 PER 30 DAYS) ATOMOXETINE CAP 80MG STRATTERA ADDITION 10/1/ QL (60 PER 30 DAYS) ATOMOXETINE CAP 100MG STRATTERA ADDITION 10/1/ QL (60 PER 30 DAYS) XATMEP SOL 2.5MG/ML METHOTREXATE ADDITION 10/1/ PA AMPICILLIN SUS 125/5ML AMPICILLIN DELETION 10/1/ AMPICILLIN SUS 250/5ML AMPICILLIN DELETION 10/1/ MENHIBRIX INJ MENINGOCOCCAL POLY AND HAEMOPHILUS B CONJ DELETION 10/1/ QL = Quanity Limit, 1
2 Covered Drug Name Alternate Drug Name Description of Change Effective Date of Change Tier Utilization Management Notes ARISTADA INJ 1064MG ARIPIPRAZOLE ADDITION 9/1/ BASAGLAR INJ 100UNIT INSULIN GLARGINE ADDITION 9/1/ GLYCOPYRROLATE AND ADDITION BEVESPI AER 9-4.8MCG FORMOTEROL 9/1/ ENTRESTO TAB 24-26MG SACUBITRIL AND VALSARTAN ADDITION 9/1/ ENTRESTO TAB 49-51MG SACUBITRIL AND VALSARTAN ADDITION 9/1/ PA PA ENTRESTO TAB MG SACUBITRIL AND VALSARTAN ADDITION 9/1/ PA GARDASIL INJ PAPILLOMAVIRUS VACCINE DELETION 9/1/ PA LOKARA LOT 0.05% DESONIDE DELETION 9/1/ MOLINDONE TAB HCL 10MG MOBAN DELETION 9/1/ MOLINDONE TAB HCL 25MG MOBAN DELETION 9/1/ MOLINDONE TAB HCL 5MG MOBAN DELETION 9/1/ POTIGA TAB 200MG EZOGABINE DELETION 9/1/ QL (180/30) POTIGA TAB 300MG EZOGABINE DELETION 9/1/ QL (120/30) POTIGA TAB 400MG EZOGABINE DELETION 9/1/ QL (90/30) POTIGA TAB 50MG EZOGABINE DELETION 9/1/ QL (720/30) XATMEP SOL 2.5MG/ML METHOTREXATE DELETION 9/1/ PA ALUNBRIG TAB 30MG BRIGATINIB ADDITION 8/1/ PA CLOFARABINE INJ 20/20ML CLOLAR ADDITION 8/1/ PA EZETIM/SIMVA TAB 10-10MG VYTORIN ADDITION 8/1/ QL (30 PER 30 DAYS), (90) EZETIM/SIMVA TAB 10-20MG VYTORIN ADDITION 8/1/ QL (30 PER 30 DAYS), (90) QL = Quanity Limit, 2
3 Covered Drug Name Alternate Drug Name Description of Change Effective Date of Change Tier Utilization Management Notes EZETIM/SIMVA TAB 10-80MG VYTORIN ADDITION 8/1/ QL (30 PER 30 DAYS), (90) IMFINZI INJ 120/2.4 DURVALUMAB ADDITION 8/1/ PA IMFINZI INJ 500/10 DURVALUMAB ADDITION 8/1/ PA KISQALI 200 PAK FEMARA RIBOCICLIB AND LETROZOLE ADDITION 8/1/ PA KISQALI 400 PAK FEMARA RIBOCICLIB AND LETROZOLE ADDITION 8/1/ PA KISQALI 600 PAK FEMARA RIBOCICLIB AND LETROZOLE ADDITION 8/1/ PA RYDAPT CAP 25MG MIDOSTAURIN ADDITION 8/1/ PA XATMEP SOL 2.5MG/ML METHOTREXATE ADDITION 8/1/ PA ZEJULA CAP 100MG NIRAPARIB ADDITION 8/1/ PA GARDASIL INJ PAPILLOMAVIRUS VACCINE DELETION 8/1/ PA PEG-INTRON KIT 150 RP PEGINTERFERON ALFA-2b DELETION 8/1/ QL (4 PER 28 DAYS), PA PEG-INTRON KIT 50MCG RP PEGINTERFERON ALFA-2b DELETION 8/1/ QL (4 PER 28 DAYS), PA PEG-INTRON KIT 80MCG RP PEGINTERFERON ALFA-2b DELETION 8/1/ QL (4 PER 28 DAYS), PA BAVENCIO INJ 20MG/ML AVELUMAB ADDITION 7/1/ PA PRISTIQ 2 DESVENLAFAX TAB 100MG ER ADDITION 7/1/2017 QL (30 PER 30 DAYS) DESVENLAFAX TAB 25MG ER PRISTIQ ADDITION 7/1/ QL (240 PER 30 DAYS) DESVENLAFAX TAB 50MG ER PRISTIQ ADDITION 7/1/ QL (240 PER 30 DAYS) PIRFENIDONE 5 ESBRIET TAB 267MG ADDITION 7/1/2017 QL (270 PER 30 DAYS), PA ESBRIET TAB 801MG PIRFENIDONE ADDITION 7/1/ QL (90 PER 30 DAYS), PA LEVOLEUCOVOR INJ 50MG FUSILEV ADDITION 7/1/ PA NITROGLYCERN SUB 0.3MG NITROSTAT ADDITION 7/1/ OSELTAMIVIR CAP 30MG TAMIFLU ADDITION 7/1/ QL (84 PER 180 DAYS) OSELTAMIVIR CAP 45MG TAMIFLU ADDITION 7/1/ QL (42 PER 180 DAYS) OSELTAMIVIR CAP 75MG TAMIFLU ADDITION 7/1/ QL (42 PER 180 DAYS) VIRAZOLE INH 6GM RIBAVIRIN DELETION 7/1/ PA QL = Quanity Limit, 3
4 Covered Drug Name Alternate Drug Name Description of Change Effective Date of Change Tier Utilization Management Notes BUTRANS DIS 10MCG/HR BUPRENORPHINE ADDITION 6/1/ QL (4 PER 28 DAYS) BUTRANS DIS 15MCG/HR BUPRENORPHINE ADDITION 6/1/ QL (4 PER 28 DAYS) BUTRANS DIS 20MCG/HR BUPRENORPHINE ADDITION 6/1/ QL (4 PER 28 DAYS) BUTRANS DIS 5MCG/HR BUPRENORPHINE ADDITION 6/1/ QL (4 PER 28 DAYS) BUTRANS DIS 7.5/HR BUPRENORPHINE ADDITION 6/1/ QL (4 PER 28 DAYS) BYDUREON INJ BYDUREON INJ EXENATIDE EXTENDED RELEASE EXENATIDE EXTENDED RELEASE TIER REDUCTION 6/1/ QL (4 PER 28 DAYS) TIER REDUCTION 6/1/ QL (4 PER 28 DAYS) FARXIGA TAB 10MG DAPAGLIFLOZIN ADDITION 6/1/ FARXIGA TAB 5MG DAPAGLIFLOZIN ADDITION 6/1/ FLECTOR DIS 1.3% DICLOFENAC ADDITION 6/1/ HYSINGLA ER TAB 100 MG HYDROCODONE EXTENDED- RELEASE ADDITION 6/1/ QL (60 PER 30 DAYS) HYSINGLA ER TAB 120 MG HYDROCODONE EXTENDED- RELEASE ADDITION 6/1/ QL (60 PER 30 DAYS) HYSINGLA ER TAB 20 MG HYDROCODONE EXTENDED- RELEASE ADDITION 6/1/ QL (60 PER 30 DAYS) HYSINGLA ER TAB 30 MG HYDROCODONE EXTENDED- RELEASE ADDITION 6/1/ QL (60 PER 30 DAYS) HYSINGLA ER TAB 40 MG HYDROCODONE EXTENDED- RELEASE ADDITION 6/1/ QL (60 PER 30 DAYS) HYSINGLA ER TAB 60 MG HYDROCODONE EXTENDED- RELEASE ADDITION 6/1/ QL (60 PER 30 DAYS) HYSINGLA ER TAB 80 MG HYDROCODONE EXTENDED- RELEASE ADDITION 6/1/ QL (60 PER 30 DAYS) KISQALI TAB 200DOSE RIBOCICLIB ADDITION 6/1/ PA QL = Quanity Limit, 4
5 Covered Drug Name Alternate Drug Name Description of Change Effective Date of Change Tier Utilization Management Notes KISQALI TAB 400DOSE RIBOCICLIB ADDITION 6/1/ PA KISQALI TAB 600DOSE RIBOCICLIB ADDITION 6/1/ PA TIER OXYCODONE OXYCONTIN TAB 10MG CR REDUCTION 6/1/ QL (90 PER 30 DAYS) TIER OXYCODONE OXYCONTIN TAB 15MG CR REDUCTION 6/1/ QL (90 PER 30 DAYS) TIER OXYCODONE OXYCONTIN TAB 20MG CR REDUCTION 6/1/ QL (90 PER 30 DAYS) TIER OXYCODONE OXYCONTIN TAB 30MG CR REDUCTION 6/1/ QL (90 PER 30 DAYS) TIER OXYCODONE OXYCONTIN TAB 40MG CR REDUCTION 6/1/ QL (90 PER 30 DAYS) TIER OXYCODONE OXYCONTIN TAB 60MG CR REDUCTION 6/1/ QL (90 PER 30 DAYS) OXYCONTIN TAB 80MG CR OXYCODONE TIER REDUCTION 6/1/ QL (90 PER 30 DAYS) TRULICITY INJ 0.75/0.5 DULAGLUTIDE ADDITION 6/1/ QL (2 PER 28 DAYS) TRULICITY INJ 1.5/0.5 DULAGLUTIDE ADDITION 6/1/ QL (2 PER 28 DAYS) XIGDUO XR TAB DAPAGLIFLOZIN AND METFORMIN EXTENDED- RELEASE ADDITION 6/1/ XIGDUO XR TAB MG DAPAGLIFLOZIN AND METFORMIN EXTENDED- RELEASE ADDITION 6/1/ XIGDUO XR TAB MG DAPAGLIFLOZIN AND METFORMIN EXTENDED- RELEASE ADDITION 6/1/ QL = Quanity Limit, 5
6 Covered Drug Name Alternate Drug Name Description of Change Effective Date of Change Tier Utilization Management Notes XIGDUO XR TAB 5-500MG DAPAGLIFLOZIN AND METFORMIN EXTENDED- RELEASE ADDITION 6/1/ SELZENTRY TAB 25MG MARAVIROC ADDITION 5/1/ SELZENTRY TAB 75MG MARAVIROC ADDITION 5/1/ APREPITANT CAP 40MG EMEND ADDITION 5/1/ QL (30 PER 30 DAYS), PA APREPITANT CAP 80MG EMEND ADDITION 5/1/ QL (30 PER 30 DAYS), PA APREPITANT CAP 125MG EMEND ADDITION 5/1/ QL (30 PER 30 DAYS), PA MIRCERA INJ 50MCG METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA ADDITION 5/1/ PA MIRCERA INJ 75MCG METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA ADDITION 5/1/ PA MIRCERA INJ 100MCG METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA ADDITION 5/1/ PA MIRCERA INJ 200MCG METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA ADDITION 5/1/ PA ASA/DIPYRIDA CAP MG AGGRENOX ADDITION 5/1/ QL (60 PER 30 DAYS) AMIFOSTINE INJ 500MG AMIFOSTINE DELETION 4/1/ PA AMIODARONE TAB 100MG PACERONE ADDITION 4/1/ DOXYCYCL HYC INJ 100MG DOXY DELETION 4/1/ PA LOPIN/RITON SOL 80-20/ML KALETRA ADDITION 4/1/ QL (480 PER 30 DAYS) MENOMUNE INJ A/C/Y/W MENINGOCOCCAL POLYSACCHARIDE VACCINE DELETION 4/1/ NECON TAB 1/35 ETHINYL ESTRADIOL AND NORETHINDRONE DELETION 4/1/ MOP CAP 10MG METHOXSALEN DELETION 3/1/ PA QL = Quanity Limit, 6
7 Covered Drug Name Alternate Drug Name Description of Change Effective Date of Change Tier Utilization Management Notes ABACA/LAMIVU TAB EPZICOM ADDITION 3/1/ QL (30 PER 30 DAYS) A-HYDROCORT INJ 100MG CORTEF DELETION 3/1/ PA BUPROBAN TAB 150MG BUPROPION DELETION 3/1/ QL (90 PER 30 DAYS) CERVARIX INJ HUMAN PAPILLOMAVIRUS (HPV) BIVALENT(TYPES 16,18) RECMB VAC DELETION 3/1/ DOCEFREZ INJ 20MG DOCETAXEL DELETION 3/1/ PA ERGOMAR SUB 2MG ERGOTAMINE DELETION 3/1/ EZETIMIBE TAB 10MG ZETIA ADDITION 3/1/ QL (30 PER 30 DAYS) GENGRAF CAP 50MG NEORAL ADDITION 3/1/ PA KYPROLIS SOL 30MG CARFILZOMB ADDITION 3/1/ PA KYPROLIS SOL 60MG CARFILZOMB ADDITION 3/1/ PA LANTUS INJ SOLOSTAR INSULIN GLARGINE ADDITION 3/1/ QL (30 PER 30 DAYS) LARTRUVO INJ 10MG/ML OLARATUMAB ADDITION 3/1/ PA MENEST TAB 2.5MG ESTERIFIED ESTROGENS DELETION 3/1/ METHOTREXATE INJ 25MG/ML METHOTREXATE ADDITION 3/1/ PA NAPHAZOLINE SOL 0.1% OP NAPHAZOLINE DELETION 3/1/ NIFEDICAL XL TAB 30MG PROCARDIA XL, ADALAT CC DELETION 3/1/ NIFEDICAL XL TAB 60MG PROCARDIA XL, ADALAT CC DELETION 3/1/ NILUTAMIDE TAB 150MG NILANDRON ADDITION 3/1/ QL (30 PER 30 DAYS) RANITIDINE INJ 150/6ML ZANTAC DELETION 3/1/ PA RASAGILINE TAB 0.5MG AZILECT ADDITION 3/1/ RASAGILINE TAB 1MG AZILECT ADDITION 3/1/ ROSUVASTATIN TAB 10MG CRESTOR ADDITION 3/1/ QL (30 PER 30 DAYS), (90) ROSUVASTATIN TAB 20MG CRESTOR ADDITION 3/1/ QL (30 PER 30 DAYS), (90) QL = Quanity Limit, 7
8 Covered Drug Name Alternate Drug Name Description of Change Effective Date of Change Tier Utilization Management Notes ROSUVASTATIN TAB 40MG CRESTOR ADDITION 3/1/ QL (30 PER 30 DAYS), (90) ROSUVASTATIN TAB 5MG CRESTOR ADDITION 3/1/ QL (30 PER 30 DAYS), (90) RUBRACA TAB 200MG RUCAPARIB ADDITION 3/1/ PA RUBRACA TAB 300MG RUCAPARIB ADDITION 3/1/ PA STAVUDINE SOL 1MG/ML ZERIT DELETION 3/1/ QL (2400 PER 30 DAYS) TRAVOPROST DRO 0.004% TRAVATAN DELETION 3/1/ TYZEKA TAB 600MG TELBIVUDINE DELETION 3/1/ PA VITEKTA TAB 150MG ELVITEGRAVIR DELETION 3/1/ QL (30 PER 30 DAYS) VITEKTA TAB 85MG ELVITEGRAVIR DELETION 3/1/ QL (30 PER 30 DAYS) XIIDRA DRO 5% LIFITEGRAST ADDITION 3/1/ QL (60 PER 30 DAYS) YONDELIS INJ 1MG TRABECTEDIN ADDITION 3/1/ PA ZERIT SOL 1MG/ML STAVUDINE ADDITION 3/1/ QL (2400 PER 30 DAYS) QL = Quanity Limit, 8
9 Covered Drug Name Alternate Drug Name Description of Change Effective Date of Change Tier Utilization Management Notes QL = Quanity Limit, 9
10 QL = Quanity Limit, 10
11 QL = Quanity Limit, 11
12 QL = Quanity Limit, 12
13 QL = Quanity Limit, 13
14 QL = Quanity Limit, 14
15 QL = Quanity Limit, 15
16 QL = Quanity Limit, 16
17 QL = Quanity Limit, 17
18 QL = Quanity Limit, 18
Medicare Part D 2017 Formulary Changes OC Preferred
Medicare Part D 017 Formulary s OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization, quantity
Medicare Part D 2017 Formulary Changes Service To Senior
Medicare Part D 2017 Formulary s Service To Senior Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
Medicare Part D 2017 Formulary Changes Service To Senior
Medicare Part D 2017 Formulary Changes Service To Senior Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
Medicare Part D 2017 Formulary Changes OC Preferred
Medicare Part D 2017 Formulary s OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization, quantity
VIVA MEDICARE IMPORTANT T EXPANDED PERFORMANCE FORMULARY UPDATES
NORE/ETH/FER CHW 0.MG Added to the 07 //07 ALYACEN TAB / Added to the 07 //07 AMETHIA LO TAB Added to the 07 //07 ERGOT/CAFFEN TAB 00MG Added to the 07 //07 NORETH/ETHIN TAB /0 Added to the 07 //07 LORCET
2017 Medicare Part D Formulary Change
2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
2017 Medicare Part D Formulary Change
2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
2017 Medicare Part D Formulary Change
2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
Medicare Part D 2012 Formulary Changes Service To Senior and Total Fit
Medicare Part D 2012 Formulary s Service To Senior and Total Fit Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
Partners Notice of Change March 2017
New Added Products: Effective 3/1/2017 Drug Reason Tier Restrictions abacavir 600 mg-lamivudine 300 QL ADRENACLICK 0.15 MG/0.15 ML INJECTION,AUTO- INJECTOR ADRENACLICK 0.3 MG/0.3 ML INJECTION, AUTO- INJECTOR
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)
207 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Plus Plan (HMO) H5087-002, H5087-07 This is a listing of the changes that have occurred in our formulary.
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Best Plan (HMO) H5087-005 This is a listing of the changes that have occurred in our formulary. Please
2017 Formulary Addendum Notice of Change
017 Formulary Addendum Notice of Change (Medicare Advantage Plans) WellCare Health Plans WellCare Choice (HMO), WellCare Essential (HMO-POS), WellCare Value (HMO) This is a listing of the changes that
Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred
Medicare Part D 2016 Formulary s Service To Senior and OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior
2017 Formulary Addendum Notice of Change (Prescription Drug Plans)
2017 Formulary Addendum Notice of Change (Prescription Drug Plans) WellCare Prescription Insurance, Inc. WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes that have occurred
2017 Formulary Addendum Notice of Change
2017 Formulary Addendum Notice of Change (Prescription Drug Plans) WellCare Prescription Insurance, Inc. WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes that have occurred
2017 Formulary Addendum Notice of Change
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) WellCare Health Plans WellCare Access (HMO SNP), WellCare Liberty (HMO SNP), WellCare Reserve (HMO), WellCare Rx (HMO), WellCare Select
2018 Formulary Notice of Change Prescription Drug Plans
2018 Formulary Notice of Change Prescription Drug Plans WellCare Prescription Insurance, Inc. Plans in all states: WellCare Classic (PDP) WellCare may add or remove drugs from our formulary during the
2017 Formulary Changes Year to Date
2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Freedom Plan (HMO SNP) H5087-001 This is a listing of the changes that have occurred in our formulary.
Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies
Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies BlueCross BlueShield of South Carolina may add or remove drugs from the formulary during the year. If we remove drugs
Medicare Part D 2016 Formulary Changes Desert Preferred Choice
Medicare Part D 2016 Formulary s Desert Preferred Choice Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates
Aetna Better Health Illinois Premier Plan November 2015 Formulary Updates desogestrel & ethinyl estradiol tab 0.15 mg-30 mcg RIVASTIGMINE DIS 13.3/24; QL (30 patches/30 days) RIVASTIGMINE DIS 4.6MG/24;
Pharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update THIRD QUARTER 2017 Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. P&T Committee Decisions Effective August 15, 2017 Dear Healthcare
2018 Medicare Part D Formulary Change
2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
Health Partners Medicare Special (2017) Updates
March 2017 Effective Date Brand Name EVZIO erythromycin ethylsuccinate naloxone hcl Generic Name erythromycin ethylsuccinate Type of Change Previous Value New Value ofloxacin ofloxacin NAMZARIC NAMZARIC
2017 Medicare Part D Formulary Change
2017 Medicare Part D Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy restrictions
Upper Peninsula Health Plan Advantage (HMO) (H ) Updates
February, 2017 02/28/2017 abacavirlamivudine 02/28/2017 abacavirlamivudine 02/28/2017 rasagiline mesylate 02/28/2017 rasagiline mesylate abacavir sulfate/lamivudine ADD UM: QUANTITY 30 / 30 Days abacavir
2018 CareOregon Advantage Part D Formulary Changes
2018 CareOregon Advantage Part D Formulary Changes Abbreviations: AGE = Age Restriction; PA = Prior Authorization Required; QL = Quantity Limit; ST = Step Therapy Required; LD = Limited Distribution; BvD
Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary
Notice of Mid-Year s to 2019 Paramount Enhanced Formulary Paramount Elite (HMO) may immediately remove a brand name drug on our List if we are replacing it with a new generic drug that will appear on the
ICP Formulary Updates
ICP Formulary Updates July 2017 TRADE NAME (generic name) adapalene cream 0.1% 2017-07-01 Removal adapalene gel 0.3% 2017-07-01 Removal adefovir dipivoxil tab 10 mg 2017-07-01 Removal ADVAIR DISKUS (fluticasone-salmeterol
March 2017 Pharmacy & Therapeutics Committee Decisions
UCare s Pharmacy and Therapeutics Committee (P&T) is a group of physicians and pharmacists that meet throughout the year to make changes to the UCare formulary (approved drug list). These changes are reviewed
NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF CHANGES The following summary describes changes to the 2018 Presbyterian Senior Care (HMO)/(HMO-POS), Presbyterian MediCare PPO and formularies. The formulary may change at any time. You
Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions
Alameda Alliance for Health FORMULARY UPDATE Effective: October 27, 2017. Drugs notated with an * have an undetermined implementation date Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee
2019 Drug List Negative Changes
2019 Drug List Negative Changes Updated 03/26/2019 If you are taking a drug that is removed from the formulary (also known as the Drug List), we will tell you. We will also tell you if we add any restrictions
Aetna Better Health of Illinois Medicaid Formulary Updates
October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary October 1, 2018 Updates. Formulary. Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select October 1, 2018 Updates Drug Name efavirenz 600mg (Brand = Sustiva ) trientine (Brand = Syprine ) hydrocortisone lot 0.1% (Brand = Locoid ) sumatriptan-naproxen
2018 Medicare Part D Formulary Change
2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
2018 Drug List Negative Changes Updated 10/25/2018 The table below shows changes made to our 2018 List of Covered Drugs (Formulary).
2018 Drug List Negative s Updated 10/25/2018 The table below shows changes made to our 2018 List of Covered Drugs (Formulary). Date of 1/1/2018 COLYTE-FLAVOR PACKS SOLR 227.1GM- 21.5GM-5.53GM- 2.82GM-6.36GM
2019 Drug List Negative Changes
2019 Drug List Negative Changes Updated 03/26/2019 If you are taking a drug that is removed from the formulary (also known as the Drug List), we will tell you. We will also tell you if we add any restrictions
Health Partners Medicare Prime and Value (2017) Updates
March/April 2017 Effective Date Brand Name Name Type of Change Previous Value New Value SPS sodium polystyrene sulfonate/sorbitol solution ORKAMBI ADRENACLICK ADRENACLICK levalbuterol tartrate hfa EXONDYS
2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This
Quarterly Pharmacy Formulary Change Notice
MEDICAID PROVIDER BULLETIN February 26, 2015 Quarterly Pharmacy Formulary Change Notice Summary of Change: The formulary changes listed in the table below were reviewed and approved at our September 24,
Prescription benefit updates Large group
Prescription benefit updates Large group Moda Health s prescription program is a pharmacy benefit that offers members a choice of safe effective medication treatments. The program also helps you save money
Health Partners Medicare Prime 2019 Formulary Changes
Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes
HEALTH SHARE/PROVIDENCE (OHP)
HEALTH SHARE/PROVIDENCE (OHP) STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered
Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum
Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Below is a list formulary changes for the benefit year 2018. This is not a complete list of drugs covered by the Part D plan. The
Quarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Summary of change: The Pharmacy and Therapeutics Committee (P&T) reviewed and approved the formulary changes listed in the table below on March 29, 2016. What
Reason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved.
2017 Formulary Change Notice Please note these changes to your 2017 List of Covered Drugs Drug name (medication) Rubraca Aprepitant Onivyde Oseltamivir Restasis Xiidra Daptomycin Selzentry Linzess Butalb/APAP/caff
THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM
Value Based Tier Drugs are selected for the management of Asthma, Diabetes, Hypertension and Hyperlipidemia. These drugs are covered at no charge or at a reduced cost share. Medications are under continual
PDP Classic Formulary Addendum
PDP Classic Formulary Addendum The following medications have been added to the WellCare formulary as of March 2009. Drug Name Therapeutic Class Drug Tier Requirements/Limits Changes Made acetazolamide
2017 Formulary (List of Covered Drugs)
017 Formulary (List of Covered Drugs) Liberty Health Advantage Preferred Choice (HMO) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN HPMS Approved Formulary File
Pharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update FIRST QUARTER 2017 P&T Committee Decisions effective March 1, 2017 Dear Healthcare Practitioner: The Presbyterian Health Plan, Inc., and Presbyterian
August 2016 Formulary Updates
August 2016 Formulary Updates DOXYCYCLINE HYCLATE TABS DR 50MG, 200MG NALOXONE HCL INJ 0.4MG/ML VANCOMYCIN HCL INJ 500MG, 750MG BRIVIACT INJ - PA BRIVIACT ORAL SOLN - QL; PA BRIVIACT TABS - QL; PA LENVIMA
Aetna Better Health FIDA Plan
Aetna Better Health FIDA Plan May 2016 Formulary Updates ASCOMP/COD - QL; PA FYAVOLV 5MCG; 1MG- PA METOPROLOL TABS 37.5MG, 75MG CIPRODEX LETAIRIS - QL; PA OFEV - QL; PA OTREXUP - ST PRALUENT - QL; PA RASUVO
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates July 2018 TRADE NAME (generic name) or generic name ADVAIR DISKUS (fluticasone-salmeterol aer powder ba 100-50 mcg/dose) Brand Addition ADVAIR
Health Partners Medicare Prime and Value (2017) Updates
March/April 2017 Effective Date Brand Name Name Type of Change Previous Value New Value SPS sodium polystyrene sulfonate/sorbitol solution ORKAMBI ADRENACLICK ADRENACLICK levalbuterol tartrate hfa EXONDYS
CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.
ADHD STIMULANTS ATOMOXETINE HCL, DEXEDRINE 10 MG TABLET, DEXEDRINE 5 MG TABLET, DEXMETHYLPHENIDATE HCL, DEXMETHYLPHENIDATE HCL ER, DEXTROAMPHETAMINE 10 MG TAB, DEXTROAMPHETAMINE 5 MG TAB, DEXTROAMPHETAMINE
FORMULARY LIST OF COVERED DRUGS
FORMULARY LIST OF COVERED DRUGS 2018 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. HPMS Approved Formulary File Submission ID 00018248, Version Number #3 This formulary
ANGIOTENSIN RECEPTOR BLOCKERS
Step Therapy 2014 2 Tier-Alameda Last Updated: 10/10/2014 ANGIOTENSIN RECEPTOR BLOCKERS Benicar Benicar Hct Diovan Valsartan Step 1: First line therapy should be irbesartan, irbesartan/hctz, losartan,
DIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0
Metformin DIABETES (1 of 5) Glucophage Glucophage XR ER $7 (500mg) $7 (500mg) $5 $5 500mg, 750mg only 500mg, 750mg only Sulfonylurea/Combinations Amaryl Glucotrol glimepiride glipizide $5 $5 Glucotrol
Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred
Medicare Part D 2016 Formulary s Service To Senior and OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior
Michigan Department of Community Health Quantity Limitations
Abstral (fentanyl) sl tab all strength Acetaminophen Actonel Actonel 35mg Adderall XR 5mg, 10mg, 15mg 240 per 34 days 3 gm/day 2 every 28 days 4 every 28 days Advair Diskus. No more than 180 every 30 days
5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details
5-ASA DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum. 1 ANTIEMETICS
5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release
Updated 11/1/17 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda
DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019
DPP4 INHIBITORS Janumet 50 mg-1,000 mg tablet Januvia 50 mg tablet Janumet 50 mg-500 mg tablet Onglyza 2.5 mg tablet Januvia 100 mg tablet Onglyza 5 mg tablet Januvia 25 mg tablet Tradjenta 5 mg tablet
Quarterly pharmacy formulary change notice
Provider Bulletin June 24, 2016 Summary of change The Pharmacy and Therapeutics Committee reviewed and approved the formulary changes listed in the table below on March 29, 2016. What this means to you
DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet
DPP4 INHIBITORS Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet Januvia 50 mg tablet Onglyza 2.5 mg tablet Onglyza 5 mg tablet Tradjenta 5 mg tablet
Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017)
Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017) The Capital BlueCross formulary is a reference list of prescription drugs that contains a wide range of generic and brand drugs that have
Changes to the 2018 MHC CO-OP Preferred Drug List
Changes to the 2018 MHC CO-OP Preferred Drug List MHC CO-OP Individual & Small Group Plans may add or remove drugs from the Drug List during the year. If a drug is scheduled to be removed from the Drug
Subject: HPN/SHL COMMERCIAL PDL UPDATES EFFECTIVE JANUARY 1, 2018
Date: November 7, 2017 To: From: HPN/SHL Contracted Pharmacies and Providers Ryan Bitton, PharmD, MBA Senior Director, Pharmacy Subject: HPN/SHL COMMERCIAL PDL UPDATES EFFECTIVE JANUARY 1, 2018 Effective
ADHD STIMULANTS - SCORE
Step Therapy Trillium 5 Tier Effective Date: 12/01/2017 Approval Date: 10/24/2017 ADHD STIMULANTS - SCORE Strattera Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant
Department of Public Safety and Correctional Services
Department of Public Safety and Correctional Services Office of the Secretary 300 E. JOPPA ROAD SUITE 1000 TOWSON, MARYLAND 21286-3020 (410) 339-5000 FAX (410) 339-5071 TOLL FREE (877) 379-8636 V/TTY (800)
Developing a Oncology Treatment Resource for Claims-Based Research: Innovation with Medications
Developing a Oncology Treatment Resource for Claims-Based Research: Innovation with Medications Donna R. Rivera, PharmD., MSc. Scientific Project Officer and Pharmacist Surveillance Informatics Branch
Alprazolam 0.25mg, 0.5mg, 1mg tablets
Presbyterian Senior Care (HMO) / Presbyterian MediCare PPO Quantity Limits Effective November 1, 2014 For the most recent list of drugs or other questions, please contact the Presbyterian Customer Service
Quarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Provider update Summary: The formulary changes listed in the table below were reviewed and approved at our second quarter 2018, Pharmacy and Therapeutics Committee
STEP THERAPY CRITERIA
STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered under your medical or prescription
ANTICONVULSANTS. Details
ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200 mg tablet Banzel 40 mg/ml oral suspension Banzel 400 mg tablet Fycompa 0.5 mg/ml oral suspension
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Generic Additions These generic drugs recently became available in the marketplace. When these generic drugs became available, we began covering them at the
Quarterly Pharmacy Formulary Change Notice
Quarterly Pharmacy Formulary Change Notice Summary of Change: The formulary changes listed in the table below were reviewed and approved at our December 18, 2014 Value Assessment Committee (VAC) meeting.
Step Therapy Medications
Step Therapy Medications Step Therapy Group APTIOM Step-2: APTIOM 200 MG TABLET or APTIOM 400 MG TABLET or APTIOM 600 MG TABLET or APTIOM 800 MG TABLET Step 1 Drug(s): Oxcarbazepine immediate-release,
Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the Presbyterian Commercial Large Group Plans (Non-Metal Plans) Formularies effective 2018. For the most recent list of drugs,
December 2016 Formulary Updates
December 2016 Formulary Updates ABACAVIR/LAMIVUDINE AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 10-20MG QL AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 10-40MG QL AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 5-20MG QL AMLODIPINE/OLMESARTAN
WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum
WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum This is a listing of the changes that have occurred in our formulary. Please carefully review these changes and call WellCare if you
Arkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
Quarterly pharmacy formulary change notice
Provider Bulletin April 2018 This table is used by HealthKeepers, Inc. to indicate formulary changes applicable to all Anthem HealthKeepers Plus members. These changes were reviewed and approved at the
FORMULARY CHANGE NOTICE 2008 JULY
FORMULARY CHANGE NOTICE 2008 JULY Drug Name Dosage Form Strength Alternative Medicine* Formulary Formulary Change and Reason Status of Alternative Medication Updated Status On Formulary STARLIX TABS 120MG
Arkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the 2017 Presbyterian Individual and Family Metal Plan/Employer Group Metal Plan Formularies effective 2018. For the most recent
TN Cover Rx Tennessee CoverRx MAC Price Change List As of: 04/26/2018
1 Tennessee CoverRx List Run : 04/26/18 Dosage Form amiodarone HCl 200 MG TABLET ORAL 04/25/2018 0.16102 0.14405 11.8 hydralazine HCl 100 MG TABLET ORAL 04/25/2015 0.11390 0.10854 4.9 hydralazine HCl 25
Added, Removed or Changed. Date of Change. No Change
One mission: you s September 7, 2017 Blue Cross of Idaho reviews its formularies (covered drug lists) periodically to allow members access to new drugs and to provide safe, cost effective options for your
5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release
5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum.
Memorial Hermann Advantage HMO February 2019 Formulary Addendum
Memorial Hermann Advantage HMO February 2019 Formulary Addendum Changes may have occurred since the printing of your current Memorial Hermann Advantage HMO Formulary. Medications that may have been added
Presented by Sata Hackenbruck 6 August 2009 State of Oregon SAS Users Group Meeting
Presented by Sata Hackenbruck 6 August 2009 State of Oregon SAS Users Group Meeting Explore following SAS text functions: COMPRESS TRANWRD SCAN Here is the problem I am analyzing pharmacy data and I want
Arkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to